78
Views
0
CrossRef citations to date
0
Altmetric
Case Report

“Ruptured” malignant phyllodes tumor of the breast: a case report

, , &
Pages 35-37 | Published online: 22 Feb 2016

Abstract

Phyllodes tumor or cystosarcoma phyllodes is a rare disease and is usually seen in middle-aged patients. Ruptured phyllodes tumor is a very rare condition. Our study reports patient presentation, diagnosis method, and treatment of an unusual case. A 58-year-old premenopausal female was diagnosed with a phyllodes tumor and presented with a rapidly growing mass for 2 months that ruptured 1 month later. She underwent simple mastectomy at the left side of her breast and received adjuvant radiotherapy. No recurrence was found 4 months after operation.

Introduction

Phyllodes tumor or cystosarcoma phyllodes represents roughly 0.3%–0.9% of all breast tumorsCitation1 and is usually seen in patients between 40–50 years of age.Citation2 World Health Organization has divided this tumor into three subtypes – benign, borderline, and malignant. Stromal elements of these tumors often form leaf-like projections lined by epithelium. Surgery remains the mainstay of the treatment in patients with phyllodes tumor and complete surgical resection offers high rates of local control.Citation3

Ruptured phyllodes tumor is a very rare condition. Our study reports patient presentation, diagnosis method, and treatment of an unusual case admitted in the Division of Head, Neck and Breast, Chiang Mai University Hospital.

Case presentation

A 58-year-old premenopausal female with underlying diseases of Chiari I malformation with syringomyelia C1-T10 levels presented to the outpatient surgical unit in a Thai provincial hospital. She had a 2-month history of a mass in her left breast and eruption of the mass with pus through the skin for 1 month. The patient reported acceleration in the growth of the mass in the past month and also complained of occasional bleeding from the mass.

Physical examination revealed a huge mass that was ulcerated, having an irregular surface, occupying the entire left breast (). The mass bled with surface contact. There was no axillary lymphadenopathy. The right breast was normal.

Figure 1 Tumor of entire left breast (rupture size 22×18 cm).

Figure 1 Tumor of entire left breast (rupture size 22×18 cm).

CT scan of the chest was performed which showed a large inhomogeneous enhancing mass at the left breast, measuring 13.4×14.8×14.3 cm in size with a round-shaped nodule in the posterior basal segment of the left lower lung, measuring 0.6 cm in size (). The intra-abdominal organs were unremarkable.

Figure 2 CT chest shows huge inhomogeneous enhanced mass at left breast.

Abbreviation: CT, computed tomography.
Figure 2 CT chest shows huge inhomogeneous enhanced mass at left breast.

Core needle biopsy indicated a fibroepithelial neoplasm and differential diagnosis included fibroadenoma or phyllodes tumor. The patient underwent a simple mastectomy under general anesthesia. The resected specimen was 22×18 cm in size and the tumor did not invade the surrounding tissues. The specimen was sent for histopathology macroscopic examination as lobulated with focal necrosis and hemorrhage involving the entire specimen. The histopathology of the surgical specimen () revealed a malignant phyllodes tumor; 13 mitoses/10 high power field, surgical margins were approached by the tumor at the lateral and deep margins.

Figure 3 Microscopic study of phyllodes tumor.

Notes: Microscopic study of phyllodes tumor displays increased stromal cells with cleft- and leaf-like appearance of ducts and malignant spindle cells in the stroma with frequent mitoses (arrows) (H&E ×40).
Abbreviation: H&E, hematoxylin and eosin.
Figure 3 Microscopic study of phyllodes tumor.

The patient was discharged on the tenth postoperative day in a good condition with no wound complications; no recurrence was found 4 months after operation. The study protocols were approved by the Chiang Mai University Institutional Ethical Committee, Thailand and informed written patient consent was also obtained.

Discussion

Phyllodes tumors are rare especially those that rupture. From the literature review, few studies were found in the database with each study reporting only one case.Citation4Citation6 These tumors usually are presented as a well-circumscribed, firm, and mobile mass or nodule characterized by rapid growth over a short time period and classified as benign, intermediate, or malignant tumor.Citation7 Mammography and ultrasound images were difficult to distinguish between fibroadenoma and phyllodes tumors.Citation8 The histopathology of phyllodes tumors is characterized by epithelial-lined cleft-like spaces with a hypercellular stroma, organized into leaf-like fronds. Standard treatment for phyllodes tumor is surgery and the treatment of choice is wide local excisionCitation9 with adequate margin of healthy tissue (greater than 1.0 cm), but mastectomy is recommended for high tumor-to-breast ratios or when an inability to obtain adequate margins occurs. Adjuvant chemotherapy including doxorubicin and dacarbazine is rarely used for this type of breast tumor; few studies have reported that this treatment did not affect patients’ survival.Citation10,Citation11 Adjuvant radiotherapy is also controversial. Some studies have shown no improvement in the prognosis, whereas other studies have shown better local controlCitation12 but did not affect disease free survival or overall survival.Citation13 Chaney et al suggested that radiotherapy is recommended for borderline or malignant phyllodes tumors because the risk of local recurrence is high especially with positive margins, margin less than 0.5 cm, tumor size greater than 10 cm, or recurrent disease.Citation10 Most phyllodes tumor express ER and PR and endocrine therapy has no proven role in the adjuvant treatment, and ER and PR decrease expression in high-grade subgroup of phyllodes tumor.Citation14

We have reviewed the ruptured phyllodes tumor of the breast and its summary is given in .

Table 1 Literature data of patients with ruptured phyllodes tumorCitation4,Citation6,Citation15,Citation16

Conclusion

Phyllodes tumors are uncommon fibroepithelial breast tumors in which ruptures are extremely rare. There is a high index of suspicion for this tumor if a patient has a history of rapid-growth of breast mass. Phyllodes tumors often appear on ultrasound and mammo graphy and are difficult to distinguish from fibroadenoma. A simple mastectomy is performed only if negative margins cannot be obtained by wide local excision. Inadequate surgical management may lead to local recurrence. Adjuvant radiotherapy is considered in individual patients.

Disclosure

The authors report no conflicts of interest in this work.

References

  • GuerreroMABallardBRGrauAMMalignant phyllodes tumor of the breast: review of the literature and case report of stromal overgrowthSurg Oncol2003121273712689668
  • SpitaleriGToescaABotteriEBreast phyllodes tumor: a review of literature and a single center retrospective series analysisCrit Rev Oncol Hematol201388242743623871531
  • MacdonaldOKLeeCMTwardJDChappelCDGaffneyDKMalignant phyllodes tumor of the female breastCancer200610792127213316998937
  • NabiJAkhterSMAuthoyFNA case of large phyllodes tumor causing “rupture” of the breast: a unique presentationCase Rep Oncol Med2013201387129223762692
  • WalravensCDe GreefCGiant phyllodes tumour of the breastJ Plast Reconstr Aesthet Surg20086110e9e1118042445
  • WijeyaratneSMBreast “rupture” due to a phyllodes tumourBMJ Case Rep20102010
  • GrenierJDelbaldoCZelekLPiedboisPTumeurs phyllodes et sarcomes du sein: mise au point [Phyllodes tumors and breast sarcomas: a review]Bull Cancer201097101197120720855241
  • GuerreroMABallardBRGrauAMMalignant phyllodes tumor of the breast: review of the literature and case report of stromal overgrowthSurg Oncol2003121273712689668
  • RobertsNRunkDMAggressive malignant phyllodes tumorInt J Surg Case Rep20158C16116525697402
  • ChaneyAWPollackAMcNeeseMDZagarsGKAdjuvant radiotherapy for phyllodes tumor of breastRadiat Oncol Investig199866264267
  • Morales-VásquezFGonzalez-AnguloAMBroglioKAdjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breastBreast J200713655155617983394
  • PandeyMMathewAKattoorJMalignant phyllodes tumorBreast J20017641141611843853
  • GnerlichJLWilliamsRTYaoKJaskowiakNKulkarniSAUtilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998–2009Ann Surg Oncol20142141222123024306659
  • TseGMKLeeCSKungFYLHormonal receptors expression in epithelial cells of mammary phyllodes tumors correlates with pathologic grade of the tumor: a multicenter study of 143 casesAm J Clin Pathol2002118452252612375638
  • JakaRCKumarKMGopinathKSSpontaneous expulsion of benign phyllodesBreast J200915330919645792
  • SaeedSAliAMemonASGiant malignant phyllodes tumor at a tertiary care hospital of Karachi, PakistanJ Pioneer Med Sci201443143145